Free Newsletter
How to merge Roche and Genentech
Free newsletter via e-mail
Tools
Want a primer on the legal ins and outs of Roche's bid for Genentech? We don't blame you. Between state and federal laws and the two companies' own affiliation agreement, the deal could get pretty complicated. Luckily, DealBook has obliged. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
